Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis Article

sustainable development goals

publication date

  • December 1, 2024

webpage

published in

keywords

  • antiangiogenic therapy
  • bladder cancer
  • clinical outcomes
  • combination therapy
  • immune checkpoint inhibitors
  • immunotherapy
  • metastatic urothelial cancer
  • tyrosine kinase inhibitors
  • urothelial cancer

start page

  • 300

end page

  • 312

volume

  • 10

issue

  • 4